Providing seamless workflow and scalability
Through the PRIME-XV media platform, and a range of media optimization and manufacturing services, we offer advanced cell culture media solutions for stem and primary cells to support basic, translational, and clinical research, as well as commercial applications.
PRIME-XV media and supplements
Featuring chemically-defined, xeno-free, and serum-free, formulations, the platform is precisely developed and rigorously tested to ensure the consistent delivery of sufficient cell populations with the desired functionality and phenotype for therapeutic applications.
Designed to support cutting-edge therapies at every stage of development, the platform is cGMP manufactured using raw ingredients from a strictly controlled supply chain to minimize risk from adventitious agents and features document packets to facilitate the regulatory submission process.
Media Development, Optimization, and Manufacture
Cell and gene therapies frequently require individualized support and media optimization. With more than five decades of experience supporting commercial biotherapeutics, we have cultivated deep industry insight, cell culture media expertise, and a legacy of unrivaled customer service—positioning us as the cell culture media partner of choice to support your cell and gene therapy custom media needs.
We also offer process optimization for media and protocols, as well as custom manufacturing and packaging at any scale—from 10-10,000 L (liquid), or 1-7000 kg (dry powder).
At a Glance
Human mesenchymal stem cell / mesenchymal stromal cell (MSC) expansion xeno-free, serum-free medium.
Cellnest recombinant peptide is a chemically defined, animal component-free matrix polypeptide substrate based on human collagen type I.
Chemically-defined, animal component-free medium for T cell culture optimized to deliver consistent growth while maintaining T cell functionality and potency.
Serum-free medium for enrichment of CSCs from solid tumors. Formulated to provide optimal enrichment of cancer initiating stem cells (CSCs) from solid tumors.